Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD)

Condition:   Neovascular Age-related Macular Degeneration Interventions:   Drug: Zoledronic Acid 4 MG in 5 ML Injection;   Drug: Placebos Sponsor:   Oslo University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials